KRRO logo

Korro Bio (KRRO)

Profile

Full Name

Korro Bio, Inc.

Ticker Symbol

KRRO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 3, 2019

Indexes

Not included

Website

http://www.korrobio.com

Employees

104

Key Details

Price

$13.40(+4.36%)

Market cap

$125.81M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.27M

Annual EPS

-$9.37(+82.35% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$13.40
KRRO price is $13.40

30-Day Relative Volume

0.84
KRRO 30-day relative volume is 0.84

Price Performance

Price Most recent change

+4.36%
KRRO price was up +4.36% on Apr 15, 2025

Price YTD change

-64.8%
KRRO price is down -64.8% since January 1st

Price 1-year change

-81.74%
KRRO price is down -81.74% year-on-year

Price 3-year change

-
KRRO price 3-year change is unknown

Price Range

Price All-time high

$98.00
KRRO price is currently -86.33% below its historical high of $98.00

Price 3-year low

$9.15
KRRO price is currently +46.45% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$125.81M
KRRO market capitalization is $125.81 million

Market cap 3-year change

-
KRRO market capitalization 3-year change is unknown

Market cap All-time high

$732.33M
KRRO market capitalization is currently -82.82% below its historical high of $732.33 million

Market cap sector rank

51.4%
KRRO market capitalization is higher than 51.4% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+17.03%
KRRO shares outstanding is up +17.03% year-on-year

Shares Outstanding 3-Year Change

-
KRRO shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.47
KRRO beta is 1.47

200-day SMA

$39.76
KRRO price is currently -66.29% below its 200-day simple moving average

50-day SMA

$23.06
KRRO price is currently -41.89% below its 50-day simple moving average

RSI

31.70
KRRO 14-day relative strength index is 31.70

Volume

0.84
KRRO 30-day relative volume is 0.84

ATR

$1.96
KRRO average true range is $1.96

10-day Historical Volatility

126.14%
KRRO 10-day historical volatility is 126.14%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.27M
KRRO annual revenue is $2.27 million

Revenue Analysts estimate

$250.00K
KRRO annual revenue is currently +808.40% higher than the consensus analysts' forecast

Revenue 1-year change

-
KRRO annual revenue 1-year change is unknown

Revenue Sector rank

16.31%
KRRO annual revenue is higher than 16.31% of companies in Healthcare sector

EPS

EPS

-$9.37
KRRO annual earnings per share is -$9.37

EPS Analysts estimate

-$10.12
KRRO annual earnings per share is currently -7.38% lower than the consensus analysts' forecast

EPS 1-year change

+82.35%
KRRO annual earnings per share is up +82.35% year-on-year

EPS Sector rank

12.59%
KRRO annual earnings per share is higher than 12.59% of companies in Healthcare sector

Profit

Gross profit

-
KRRO annual gross profit value is unknown

Gross margin

-
KRRO annual gross profit margin value is unknown

Operating profit

-$91.91M
KRRO annual operating income is -$91.91 million

Operating margin

-4047.12%
KRRO annual operating profit margin is -4047.12%

Net income

-$83.58M
KRRO annual net profit is -$83.58 million

Net margin

-3680.36%
KRRO annual net profit margin is -3680.36%

Expenses

Total expenses

$94.18M
KRRO annual total expenses is $94.18 million

Operating expenses

$94.18M
KRRO annual total operating expenses is $94.18 million

Cost of goods sold

-
KRRO annual cost of goods sold value is unknown

Selling, general & administrative expenses

$30.55M
KRRO annual SGA is $30.55 million

Depreciation and amortization

$3.56M
KRRO annual depreciation & amortization is $3.56 million

Interest expense

-
KRRO annual interest expense value is unknown

Income tax

$141.00K
KRRO annual income tax is $141.00 thousand

EBIT & EBITDA

EBIT

-$91.91M
KRRO annual earnings before interest & taxes is -$91.91 million

EBITDA

-$88.34M
KRRO annual EBITDA is -$88.34 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$226.24M
KRRO annual total assets is $226.24 million

Non current assets

$94.71M
KRRO annual long term assets is $94.71 million

Current assets

$131.53M
KRRO annual total current assets is $131.53 million

Cash and cash equivalents

$55.64M
KRRO annual cash & cash equivalents is $55.64 million

Accounts receivable

$1.70M
KRRO annual accounts receivable is $1.70 million

Inventory

-
KRRO annual inventory value is unknown

Liabilities

Total liabilities

$65.83M
KRRO annual total liabilities is $65.83 million

Long term liabilities

$50.87M
KRRO annual total long term liabilities is $50.87 million

Current liabilities

$14.96M
KRRO annual total current liabilities is $14.96 million

Accounts payable

$3.99M
KRRO annual accounts payable is $3.99 million

Debt

Total debt

$44.77M
KRRO annual total debt is $44.77 million

Total debt 1-year change

+34.81%
KRRO annual total debt is up +34.81% year-on-year

Long term debt

$43.48M
KRRO annual long term debt is $43.48 million

Short term debt

$1.28M
KRRO annual short term debt is $1.28 million

Equity & Capital

Shareholders equity

$160.41M
KRRO annual stockholders equity is $160.41 million

Book value

$160.41M
KRRO annual book value is $160.41 million

Retained earnings

-$266.59M
KRRO annual retained earnings is -$266.59 million

Working capital

$116.57M
KRRO annual working capital is $116.57 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$60.07M
KRRO annual cash flow from operations is -$60.07 million

Cash from operations 1-year change

+10.71%
KRRO annual cash flow from operations is up +10.71% year-on-year

Cash from investing

-$123.35M
KRRO annual cash flow from investing activities is -$123.35 million

Cash from investing 1-year change

-1204.86%
KRRO annual cash flow from investing activities is down -1204.86% year-on-year

Cash from financing

$69.36M
KRRO annual cash flow from financing activities is $69.36 million

Cash from financing 1-year change

-63.06%
KRRO annual cash flow from financing activities is down -63.06% year-on-year

CAPEX

CAPEX

$17.90M
KRRO annual capital expenditures is $17.90 million

CAPEX 1-year change

-
KRRO annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$77.98M
KRRO annual free cash flow is -$77.98 million

Free cash flow 1-year change

-3.8%
KRRO annual free cash flow is down -3.8% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
KRRO annual gross profit margin value is unknown

Operating margin

-4047.12%
KRRO annual operating profit margin is -4047.12%

Net margin

-3680.36%
KRRO annual net profit margin is -3680.36%

ROA & ROE

ROA

-36.94%
KRRO annual return on assets is -36.94%

ROE

-50.61%
KRRO annual return on equity is -50.61%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
KRRO price to earnings ratio value is unknown

PE ratio Sector rank

-
KRRO price to earnings ratio is unknown

PB Ratio

PB ratio

0.78
KRRO price to book ratio is 0.78

PB ratio Sector rank

38.85%
KRRO price to book ratio is higher than 38.85% of companies in Healthcare sector

PS Ratio

PS ratio

55.40
KRRO price to sales ratio is 55.40

PS ratio Sector rank

92.82%
KRRO price to sales ratio is higher than 92.82% of companies in Healthcare sector

Enterprise value

Enterprise value

$114.93M
KRRO enterprise value is $114.93 million

Enterprise value Sector rank

51.94%
KRRO enterprise value is higher than 51.94% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.30
KRRO EV/EBITDA is -1.30

EV/EBITDA Sector rank

39.25%
KRRO EV/EBITDA is higher than 39.25% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

8.79
KRRO annual current ratio is 8.79

Quick ratio

-
KRRO annual quick ratio value is unknown

Leverage

Debt to equity

0.00
KRRO annual debt to equity ratio is 0.00

Interest coverage ratio

-
KRRO annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
KRRO piotroski f-score value is unknown

Altman Z-Score

-1.22
KRRO altman z-score is -1.22

Analyst ratings

Recent major analysts updates

Mar 20, 25 HC Wainwright & Co.
Buy
Mar 19, 25 RBC Capital
Outperform
Nov 22, 24 HC Wainwright & Co.
Buy
Nov 18, 24 Jones Trading
Buy
Nov 13, 24 HC Wainwright & Co.
Buy
Oct 21, 24 Raymond James
Strong Buy
Oct 21, 24 RBC Capital
Outperform
Oct 18, 24 HC Wainwright & Co.
Buy
Sep 19, 24 RBC Capital
Outperform
Sep 17, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

SEER logo
Seer (SEER)
PRQR logo
ProQR Therapeutics NV (PRQR)
SERA logo
Sera Prognostics (SERA)
FATE logo
Fate Therapeutics (FATE)
CHRS logo
Coherus BioSciences (CHRS)
CGEN logo
Compugen (CGEN)
RGLS logo
Regulus Therapeutics (RGLS)
THTX logo
Theratechnologies (THTX)
SGHT logo
Sight Sciences (SGHT)
  • What is the ticker symbol for Korro Bio?
  • Does Korro Bio pay dividends?
  • What sector is Korro Bio in?
  • What industry is Korro Bio in?
  • What country is Korro Bio based in?
  • When did Korro Bio go public?
  • Is Korro Bio in the S&P 500?
  • Is Korro Bio in the NASDAQ 100?
  • Is Korro Bio in the Dow Jones?
  • When was Korro Bio's last earnings report?
  • When does Korro Bio report earnings?
  • Should I buy Korro Bio stock now?

What is the ticker symbol for Korro Bio?

The ticker symbol for Korro Bio is NASDAQ:KRRO

Does Korro Bio pay dividends?

No, Korro Bio does not pay dividends

What sector is Korro Bio in?

Korro Bio is in the Healthcare sector

What industry is Korro Bio in?

Korro Bio is in the Biotechnology industry

What country is Korro Bio based in?

Korro Bio is headquartered in United States

When did Korro Bio go public?

Korro Bio's initial public offering (IPO) was on October 3, 2019

Is Korro Bio in the S&P 500?

No, Korro Bio is not included in the S&P 500 index

Is Korro Bio in the NASDAQ 100?

No, Korro Bio is not included in the NASDAQ 100 index

Is Korro Bio in the Dow Jones?

No, Korro Bio is not included in the Dow Jones index

When was Korro Bio's last earnings report?

Korro Bio's most recent earnings report was on Mar 18, 2025

When does Korro Bio report earnings?

The next expected earnings date for Korro Bio is May 14, 2025

Should I buy Korro Bio stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page